1[1]Moll R, Schiller DL, Franke WW. Identification of protein IT of the intestinal cytoskeleton as a novel type I cytokeratin with unusual properties and expression patterns. J Cell Biol,1990;111:567～80
2[2]Vander Velden LA, Schaafsma HE, Manni JJ et al. Cytokeratin expression in normal and (pre) malignant head and neck epithelia: a review. Head Neck, 1993;15:133
3[3]Heyden A, Huitfeldt HS, Koppang HS et al. Cytokeratins as epithelia differentiation markers in premalignant and malignant oral lesions. J Oral Pathol Med, 1992;21:7
4[4]Broers JLV, Klein, RM, Oostendorp T et al. Immunocytochemical detection of human lung cancer heterogeneity using antibodies to epithelial,neuronal and neuroendocrine antigens. Cancer Res,1987;47:3225～34
5[5]Broers JLV, Rameakers FC, Rot MK et al. Cytokeratins in different types of human lung cancers as monitored by chain specific monoclonal antibodies. Cancer Res,1988;48:3221～29
6[6]Vinores SA, Bornin JM, Rubinstein IJ et al. Immunohistochemical demonstration of neuron-specific enolase in neoplasms of CNS and other tissues. Arch Pathol Lab Med, 1984;108:536～40
7[7]Deftos LJ, Linnolia RI, Carney DN et al. Demonstration of chromogranin A in human neuroendocrine cell lines by immunohistology and immunoassay. Cancer, 1988;62:92～7
8[8]Helman LJ, Gazdar A, Ahn TG et al. Patterns of gene expression: a novel approach to tumor classification abstract. Proc Am Soc Clin Oncol,1987;6;9
9[9]Oian XL, Dougall WC, Hellman ME et al. Kinase deficient neu proteins supress epidermal growth factor function and abolish cell transformation. Oncogene,1994;9(5):1509～14
10[10]Eskstrand AJ,James CD, Cavenee WK et al. Genes for epidermal growth factor and their expression in human gliomas in vivo. Cancer Res, 1991;51:2164～72
